Status:

COMPLETED

Sensory Analysis and Taste Modulation of Ketone Esters

Lead Sponsor:

Monell Chemical Senses Center

Collaborating Sponsors:

HVMN (funding; holder of primary Department of Defense STTR contract)

Conditions:

Flavor Perception in Normal, Healthy Adults

Eligibility:

All Genders

21-45 years

Phase:

NA

Brief Summary

Ketone ester (KE) drinks are sold commercially in the USA and elsewhere (the FDA has accepted a GRAS (generally regarded as safe) notification on the KEs we propose to study). KE drinks can have benef...

Eligibility Criteria

Inclusion

  • Good general health (self report)
  • Men and women
  • Age from 21 to 45

Exclusion

  • Current (or within the last four weeks) acute illness, such as cold or flu
  • Currently active allergies
  • Regular use of medication (over the counter or prescription), except for birth control.
  • Any history of food allergy or sensitivity (particularly to KE drinks or MSG). Any history of sensitivity to 6-Propylthiouracil (bitter compound frequently used to assess individual differences in sensitivity to bitterness).
  • Pregnant, nursing, or trying to become pregnant during the study (pregnancy can affect flavor perception)
  • Chronic illness (any ongoing condition that is serious or required medical monitoring), including kidney problems, liver problems, cardiovascular problems (e.g., heart disease or high blood pressure), diabetes, HIV infection, or other ongoing illness). Diabetes or other metabolic issues could be important for safety as well as quality of data.
  • History of taste problems (absent or abnormal sense of taste)
  • Weigh less than 100 pounds (45.4 kilograms). This is to help ensure that the amount of KE drink consumed remains below the single serving in the GRAS (generally regarded as safe) notice which the FDA has accepted.

Key Trial Info

Start Date :

August 30 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 4 2021

Estimated Enrollment :

19 Patients enrolled

Trial Details

Trial ID

NCT04289454

Start Date

August 30 2020

End Date

June 4 2021

Last Update

March 21 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Monell Chemical Senses Center

Philadelphia, Pennsylvania, United States, 19014